Peter Milligan is retiring after seven successful years as CEO of Pharmetheus, and the board has appointed Jonas Möller as his successor. Pharmetheus, founded in 2012, began its growth trajectory under the leadership of Peter Milligan, who became CEO in 2018. With his experience at companies like Pfizer and in-depth knowledge of the pharmacometrics field, he helped grow the company to a leading position, serving a diverse portfolio of pharmaceutical clients and contributing to drug development through its expertise in quantitative approaches.
